StockData

Niki BioSolutions, Inc. (NIKI) stock

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.60+0.10 (+6.67%)

Close on Nov 18, 2026Market cap $13.03MP/E –Yield –

Niki BioSolutions pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Niki BioSolutions's pe ratio was 72.0× on Feb 28, 2022.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Feb 28, 202272.0×−3.0
2021Dec 31, 202175.0×–

More Niki BioSolutions figures

See a number that looks wrong?